Hepatocellular carcinoma (HCC) is one of the most prevalent cancers globally. In contrast to
the declining death rates observed for all other common cancers such as breast, lung, and …

Hepatocellular carcinoma (HCC) is the fifth most common cancer and the second leading
cause of cancer-related deaths worldwide. Although the prognosis of patients with HCC is …

Hepatocellular carcinoma (HCC) is a cause of several deaths related to cancer worldwidely.
In early stage, curative treatments such as surgical resection, liver transplant and local …

Hepatocellular carcinoma (HCC) is the third leading cause of cancer deaths worldwide. The
HCC diagnosis is usually achieved by biomarkers, which can also help in prognosis …

The prevalence of hepatocellular carcinoma (HCC) worldwide parallels that of persistent
infection with the hepatitis B virus (HBV) and/or hepatitis C virus (HCV). According to …

Hepatocellular carcinoma (HCC) is the most common primary liver malignancy, with
increasing global incidence. Morbidity and mortality associated with HCC remains high, and …

The established biomarker for hepatocellular carcinoma (HCC), serum α-fetoprotein (AFP),
has suboptimal performance in early disease stages. This study aimed to develop a …

MicroRNAs (miRNAs) are highly conserved, small, 18–25 nucleotide, non-coding RNAs that
regulate gene expression at the post-transcriptional level. Each miRNA can regulate …

Hepatocellular carcinoma (HCC) is an increasing health problem, representing the second
cause of cancer-related mortality worldwide. The major risk factor for HCC is cirrhosis. In …

Hepatocellular carcinoma (HCC) is a common cause of cancer-related deaths worldwide.
Despite advances in systemic therapies, patient survival remains low due to late diagnosis …